Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview

S Marchisello, A Di Pino, R Scicali, F Urbano… - International journal of …, 2019 - mdpi.com
Nonalcoholic Fatty Liver Disease (NAFLD) represents the leading cause of liver disease in
developed countries but its diffusion is currently also emerging in Asian countries, in South …

The genetic basis of childhood obesity: A systematic review

A Vourdoumpa, G Paltoglou, E Charmandari - Nutrients, 2023 - mdpi.com
Overweight and obesity in childhood and adolescence represents one of the most
challenging public health problems of our century owing to its epidemic proportions and the …

Mitochondrial mutations and genetic factors determining NAFLD risk

SA Dabravolski, EE Bezsonov, MS Baig… - International journal of …, 2021 - mdpi.com
NAFLD (non-alcoholic fatty liver disease) is a widespread liver disease that is often linked
with other life-threatening ailments (metabolic syndrome, insulin resistance, diabetes …

Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD

M Gupta, P Krishan, A Kaur, S Arora, N Trehanpati… - Inflammation …, 2021 - Springer
Non-alcoholic fatty liver disease (NAFLD) is a multifaceted disease allied with various
metabolic disorders, obesity and dysbiosis. Gut microbiota plays an influential role in the …

Elevated Serum Low-Density Lipoproteins-Cholesterol Levels and B1B2/B2B2 CETP Genotype Are Positively Associated with Nonalcoholic Fatty Liver Disease in …

M Perez-Robles, W Campos-Perez… - Metabolic Syndrome …, 2023 - liebertpub.com
Background: Nonalcoholic fatty liver disease (NAFLD) is generated by the interaction
between environmental and genetic factors, and the presence of metabolic alterations …

[HTML][HTML] Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions

X Li, M Li - Pharmaceuticals, 2024 - mdpi.com
Metabolic-associated steatotic liver disease (MASLD), the hepatic manifestation of metabolic
syndrome, represents a growing global health concern. The intricate pathogenesis of …

Both full length‐cholesteryl ester transfer protein and exon 9‐deleted cholesteryl ester transfer protein promote triacylglycerol storage in cultured hepatocytes

Y Liu, D Mihna, L Izem, RE Morton - Lipids, 2022 - Wiley Online Library
We previously reported that overexpression of full‐length cholesteryl ester transfer protein
(FL‐CETP), but not its exon 9‐deleted variant (∆ E9‐CETP), in an adipose cell line reduces …

[PDF][PDF] The Genetic Basis of Childhood Obesity: A Systematic Review. Nutrients 2023, 15, 1416

A Vourdoumpa, G Paltoglou, E Charmandari - 2023 - pdfs.semanticscholar.org
Overweight and obesity in childhood and adolescence represents one of the most
challenging public health problems of our century owing to its epidemic proportions and the …

[HTML][HTML] Both full length-CETP and exon 9-deleted CETP promote triacylglycerol storage in cultured hepatocytes

Y Liu, D Mihna, L Izem, RE Morton - Lipids, 2022 - ncbi.nlm.nih.gov
We previously reported that overexpression of full-length cholesteryl ester transfer protein
(FL-CETP), but not its exon 9-deleted variant (ΔE9-CETP), in an adipose cell line reduces …

Ensayo clínico comparativo de dos dietas hipocalóricas: dieta con patrón Mediterráneo, frente a dieta hipograsa en pacientes con esteatosis hepática metabólica …

C Laserna Del Gallego - 2024 - uvadoc.uva.es
La enfermedad hepática metabólica grasa (EHMG) abarca un amplio espectro que incluye
desde la esteatosis simple a la esteatohepatitis no alcohólica, lo que provoca un aumento …